Celleo Biotech develops intelligent production systems for the manufacture of cell and gene therapies, enabling scalable and compliant GMP processes tailored to diverse therapeutic modalities. This technology addresses the challenge of limited access to effective cell therapies by facilitating broader production capabilities for biotherapeutics, ultimately improving patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
The cell and gene therapy industry faces challenges in scaling up production while maintaining GMP compliance, hindering the widespread availability of these advanced therapeutics. Existing manufacturing processes often rely on manual techniques and laboratory tools, which are not optimized for commercial-scale production. This production gap limits the ability to deliver cell and gene therapies to a broader patient population.
Solution
Celleo Biotech develops intelligent production systems designed to enable scalable and compliant GMP manufacturing of cell and gene therapies. Their systems accommodate diverse processes, modalities, and business models within the cell therapy industry. By integrating deep biological knowledge with modern manufacturing approaches, Celleo aims to bridge the production gap and facilitate the transition from laboratory-scale to commercially viable therapeutic production. Their platform technologies encapsulate critical cell-manufacturing operations, engineered for rigorous process control and ease of use.
Target Audience
Celleo's primary customers include biotherapeutics developers, contract development and manufacturing organizations (CDMOs), and university medical centers involved in cell and gene therapy production.
Features
- GMP production systems designed for clinical through commercial scales
- Accommodates a diversity of cell and gene therapy processes and modalities
- Platform technologies encapsulate critical cell-manufacturing operations
- Systems engineered for rigorous process control
- Solutions developed in collaboration with biotherapeutics players, CDMOs, and university medical centers